Fasudil inhibits prostate cancer-induced angiogenesis in vitro

Publisher： Spandidos Publications

E-ISSN： 1791-2431|32|6|2795-2802

ISSN： 1021-335X

Source： Oncology Reports, Vol.32, Iss.6, 2014-01, pp. : 2795-2802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oxymatrine inhibits the proliferation of prostate cancer cells in vitro and in vivo

By              

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4129-4134

Spandidos Publications

Access to resources Recommend Favorite

Cancer-induced bone diseases

By Ogata E.  

European Journal of Cancer, Vol. 34, Iss. 2, 1998-02 ,pp. : 209-209

Elsevier

Access to resources Recommend Favorite

Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 555-562

Spandidos Publications

Access to resources Recommend Favorite

Angiogenesis Inhibition in the Treatment of Prostate Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1070-1078

Bentham Science Publishers

Access to resources Recommend Favorite

SPAG9 expression is increased in human prostate cancer and promotes cell motility, invasion and angiogenesis in vitro

By  

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2533-2540

Spandidos Publications

Access to resources Recommend Favorite